Company: APM
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001213900-25-037669
Chunk: 95

Company: Aptorum Group Ltd
Filing Date: 2025-04-30
Form: 20-F
Item: Item 4
Chunk 95
---
 Diagnostics Pte. Limited (formerly known as Aptorum Innovations Holding Pte. Limited), one
of the Company’s subsidiaries, entered into an Exclusive Licence Agreement with Accelerate Technologies to co-develop the PathsDxTest technology. The term of the Exclusive Licence Agreement is described in Exhibit 4.62 on Form 20-F filed with the SEC on April 19,
2021. Furthermore, Accelerate Technologies, the inventors of the PathsDxTest technologies in A*STAR (“ Founding Scientists”),
Paths Diagnostics Pte. Limited, and Paths Innovations Limited (formerly known as Aptorum Innovations Holding Limited), a wholly owned
subsidiary of the Company, entered into a Share Subscription & Shareholders Agreement on the same day to subscribe ordinary shares
of Paths Diagnostics Pte. Limited. The shares are subscribed and issued in two tranches, the first tranche has taken place at closing
of the Share Subscription & Shareholders Agreement, while the second tranche will take place after the certain first milestone is
met. The total number of shares subscribed by the shareholders under the Share Subscription & Shareholders Agreement is around 2.7
million. After the two tranches of subscription, Aptorum, Accelerate Technologies and the Founding Scientists are expected to control
71.23%, 14.25% and 9.53% of the share of Paths Diagnostics Pte. Limited respectively, with 4.99% of the shares reserved for its employee
share plan.

APTUS CAPITAL LIMITED, which
has since been renamed to AENEAS CAPITAL LIMITED, was always under the direct ownership of Jurchen and not under the ownership chain of
Aptorum Group. However, Aptus Asia Financial Holdings Limited (“ AAFH”), which has since been renamed to Aeneas Group Limited,
was transferred out of the Aptorum Group on November 10, 2017, to be held directly by Jurchen Investment Corporation and that subsequently,
APTUS CAPITAL LIMITED was then transferred to be under AAFH.

On May 4, 2017, Mr. Huen transferred all of the ordinary shares in
the Company he owned (in the amount of 2,230,760) to Jurchen, a company incorporated in the British Virgin Islands and wholly owned by
Mr. Huen. On October 13, 2017, as part of the Conversions (as defined below) the ordinary shares held by Jurchen were redesignated